|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net loss including non controlling interest | ||||
| Net loss attributable to ordinary shareholders | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Stock based compensation | ||||
| Deferred income taxes | ||||
| Unrealized foreign exchange loss/(profit) | ||||
| Gain on deconsolidation of subsidiaries | ||||
| Gain on fair valuation of investments | ||||
| Gain over liability settled/expense through issuance of equity shares | ||||
| Fair value losses/(profits) in financial instruments carried at fair value | ||||
| Impairment of investment | ||||
| Expected credit loss (net of reversal) | ||||
| Provision on doubtful advances and receivables | ||||
| Provision on doubtful advances and receivables, | ||||
| Adjustments, noncash items, to reconcile net income (loss) to cash provided by (used in) operating activities | ||||
| Assets written off | ||||
| Balances written off/(back) | ||||
| Gain on extinguishment of intercompany financial assets and liabilities | ||||
| Net loss attributable to non-controlling interest, net of tax | ||||
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | ||||
| Inventories | ||||
| Income taxes, net | ||||
| Accounts receivables, net | ||||
| Prepayments and other assets | ||||
| Accounts payable and accrued expenses | ||||
| Other liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities | ||||
| Purchase of property and equipment and intangible assets | ||||
| Acquisition of businesses | ||||
| Investment in mutual funds | ||||
| Proceeds from sale of mutual fund | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from business combination | ||||
| Proceeds from issue of preferred stock | ||||
| Proceeds from long-term borrowings | ||||
| Repayments of long-term borrowings | ||||
| Proceeds from issue of Ordinary Shares | ||||
| Proceeds from issue of equity shares of subsidiary | ||||
| Net proceeds/(payments) from borrowings | ||||
| Proceeds from forward purchase agreement | ||||
| Net cash generated from financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Net (decrease)/increase in cash and cash equivalents (including restricted cash) | ||||
| CashAcquiredInBusinessCombination | ||||
| Cash acquired in business combination | ||||
| Cash and cash equivalents at the beginning of the period (including restricted cash) | ||||
| Total cash and cash equivalents | ||||
| Reconciliation of cash and cash equivalents | ||||
| Cash and cash equivalents | ||||
| Restricted cash | ||||
| Supplemental disclosure of cash flow information | ||||
| Cash paid for interest, net of amounts capitalized | ||||
| Non-cash investing and financing activities | ||||
| Consideration payable in connection with acquisitions | ||||
| Interest accrued on borrowings | ||||
Loading...